Literature DB >> 25554457

The role of pulmonology in the National Health System Chronicity Strategy.

Juan José Soler-Cataluña1, Fernando Sánchez Toril2, M Carmen Aguar Benito2.   

Abstract

Longer life expectancy and the progressive aging of the population is changing the epidemiological pattern of healthcare, with a reduction in the incidence of acute diseases and a marked increase in chronic diseases. This change brings important social, healthcare and economic consequences that call for a reorganization of patient care. In this respect, the Spanish National Health System has developed a Chronicity strategy that proposes a substantial change in focus from traditional rescue medicine to patient- and environment-centered care, with a planned, proactive, participative and multidisciplinary approach. Some of the more common chronic diseases are respiratory. In COPD, this integrated approach has been effective in reducing exacerbations, improving quality of life, and even reducing costs. However, the wide variety of management strategies, not only in COPD but also in asthma and other respiratory diseases, makes it difficult to draw definitive conclusions. Pulmonologists can and must participate in the new chronicity models and contribute their knowledge, experience, innovation, research, and special expertise to the development of these new paradigms.
Copyright © 2014 SEPAR. Published by Elsevier Espana. All rights reserved.

Entities:  

Keywords:  Asma; Asthma; Atención integral; Case-management program; Chronic disease; Chronic obstructive pulmonary disease; Cronicidad; Disease-management program; Enfermedad pulmonar obstructiva crónica; Gestión de casos; Gestión de enfermedad; Integrated care program

Mesh:

Year:  2014        PMID: 25554457     DOI: 10.1016/j.arbres.2014.10.007

Source DB:  PubMed          Journal:  Arch Bronconeumol        ISSN: 0300-2896            Impact factor:   4.872


  1 in total

1.  Effectiveness of an Intervention to Improve Management of COPD using the AUDIT Methodology: Results of the Neumo-Advance Study.

Authors:  Javier de Miguel-Díez; Rodrigo Jiménez-García; Ana López de Andrés; Fernando Zaragoza Arnáez
Journal:  Clin Drug Investig       Date:  2019-07       Impact factor: 2.859

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.